col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


341 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Allergy and Clinical Immunology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jan―31 BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with Natural Killer cell features Claudia De Pasquale, Fabiana Drommi, Alessia Calabrò, Cirino Botta, Giacomo Sidoti Migliore, Paolo Carrega, et al. (+13)
2 [GO] 2025―Jan―10 Monocytic reactive oxygen species-induced T cell apoptosis impairs cellular immune response to SARS-CoV-2 mRNA vaccine Sandrine Gimenez, Emna Hamrouni, Sonia André, Morgane Picard, Calayselvy Soundaramourty, Claire Lozano, et al. (+5)
3 [GO] 2024―Dez―27 Respiratory Morbidity Before and During the COVID-19 Pandemic from Birth to 18 Months in a Swedish Birth Cohort Fanny Kelderer, Gabriel Granåsen, Sophia Holmlund, Sven Arne Silfverdal, Hilde Bamberg, Monique Mommers, et al. (+4)
4 [GO] 2024―Nov―17 COVID-19 in children: Evolving epidemiology, immunology, symptoms, diagnostics, treatment, post covid conditions, prevention strategies, and future directions Juliane Wurm, Nicole Ritz, Petra Zimmermann
5 [GO] 2024―Nov―08 Impact of biologics on the immune response to mRNA COVID-19 vaccination in patients with asthma Shu-Yi Liao, Barry Make, Michael E. Wechsler
6 [GO] 2024―Nov―02 Covid-19 mRNA vaccine allergy Ágnes Csuth, Lene Heise Garvey, Maria C. Jenmalm
7 [GO] 2024―Okt―22 Inborn errors of immunity are associated with increased COVID-19-related hospitalization and intensive care compared to the general population Hannes Lindahl, Fredrik Kahn, Åsa Nilsdotter-Augustinsson, Mats Fredrikson, Pontus Hedberg, Isabela Killander Möller, et al. (+8)
8 [GO] 2024―Jun―21 Human angiotensin converting enzyme 2 specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants Tong Lu, Chengcheng Zhang, Zhengqi Li, Yi Wei, Anne Sadewasser, Yan Yan, et al. (+18)
9 [GO] 2024―Jun―13 Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity Martin C. Runnstrom, Pedro A. Lamothe, Caterina E. Faliti, Narayanaiah Cheedarla, Alberto Moreno, Mehul S. Suthar, et al. (+34)
10 [GO] 2024―Mai―17 Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants Eileen W. Stalman, Luuk Wieske, Jim B.D. Keijser, Koos P.J. van Dam, Laura Y.L. Kummer, Maarten F. Wilbrink, et al. (+54)
11 [GO] 2024―Mrz―21 Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea Hong Jin Kim, Min-Ho Kim, Seong Jun Park, Myeong Geun Choi, Eun Mi Chun
12 [GO] 2024―Mrz―07 “A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination” Muhammad B. Khalid, Ellen Zektser, Eric Chu, Min Li, Joanna Utoh, Patrick Ryan, et al. (+21)
13 [GO] 2024―Feb―05 Biologic Therapy Does Not Increase Incidence Of COVID-19 Alyssa Osheim, Sofia Tovar, Sophia Schultz, Eric Schultz, Aleksander Nordin
14 [GO] 2024―Feb―05 Impact After Three Years Of Diagnosis Of Covid-19 In Children With Allergic Asthma Carlos Blanco-Mota, Paula López-González, Ana María Prieto-Moreno Pfeifer, Elisa Haroun Díaz, María Vázquez-De-La-Torre Gaspar, Diana Pérez-Alzate, et al. (+4)
15 [GO] 2024―Feb―05 Effect of Inhaled Corticosteroids and Bronchodilators on Outcomes in Asthma Patients with COVID-19 Infection at a Tertiary Care Center Kavitha Thiagarajan, Maryam Masood, Kenny Kwong
16 [GO] 2024―Feb―05 Incidence Of COVID-19 Is Increased In Patients With Hereditary Alpha-Tryptasemia And Indolent Systemic Mastocytosis Taylor Davis, Sofia Tovar, Sophia Schultz, Eric Schultz
17 [GO] 2024―Feb―05 Impact of COVID-19 on the Risk of Developing Severe Cutaneous Adverse Reactions Amongst Patients on Antiepileptics Elen Deng, Timothy Craig, Dinh Nguyen, Taha Al-Shaikhly
18 [GO] 2024―Feb―05 Differences In Viral Respiratory Tract Infections Among Immunodeficiency Patients And The General Population After The COVID-19 Pandemic Joseph Chiao, Alex Chi, Christen Pahk, Erin Chen, Grace Gao, Catherine Xiao, et al. (+5)
19 [GO] 2024―Feb―05 A study of the environmental drivers on asthma in pediatric patients during the COVID-19 pandemic. Ali Ayyash, Nicholas DeFelice, Alexis Zebrowski, Cindy Mei, Aman Patel, Erin Thanik
20 [GO] 2024―Feb―05 Electronic Health Record Documentation Patterns Amongst Allergy/Immunology and Primary Care Providers Across the COVID-19 Pandemic Priyal Parikh, Sunit Jariwala, Vineela Nagamalla
21 [GO] 2024―Feb―05 Race and Ethnicity Influence on Quality of Life during the COVID-19 Pandemic in Food Allergy Families Tracy Pitt, Melissa Hearrell, Xiaofan Huang, Kristen Andrews, Carla Davis
22 [GO] 2024―Feb―05 Effect of Rebamipide on Low-grade Inflammation in Post COVID-19 Syndrome Patients Vladimir Beloglazov, Igor Yatskov, Leila Dudchenko, Lawrence Dubuske
23 [GO] 2024―Feb―05 Additional Booster Doses Of COVID-19 Vaccine Enhance Neutralization Efficiency Against XBB.1.5 Elsa Sakr, Nisha Almeida, Ian Schiller, Danbing Ke, Maria Plesa, Marc-Andre Langlois, et al. (+2)
24 [GO] 2024―Feb―05 Humoral And Cellular Immune Response To Covid-19 Vaccines After Primary Vaccination With A 3-dose Scheme And Boosters Vaccines (4th And 5th Doses) In 55 Brazilian Patients With Inborn Errors Of Immunity Compared To Healthy Controls Vitor Gabriel Lopes Da Silva, Carolina Aranda, Kathleen Sullivan, Júlia Barbate Pintão, Maria Izabel Haro Azinar, Maria Isabel de Moraes-Pinto
25 [GO] 2024―Feb―05 Pre and Post COVID-19: Eight-year Longitudinal Analysis of the First 1000 Immunology and Allergy Cases Gordon Kwok Ho Chu, Jane Wong, Philip Li
26 [GO] 2024―Feb―05 A comparison of Fc receptors via single-cell RNA sequencing between Kawasaki disease and SARS-CoV-2 Ho-Chang Kuo
27 [GO] 2024―Feb―05 Immunophenotypic Risk Factors for Low SARS-CoV-2 Immunization Response in Adults with Predominantly Antibody Deficiency over Five Total Vaccine Doses Anna Zhang, AHMED ELMOURSI, Daniel Digiacomo, Baijun Zhou, Megha Tandon, Joseph Hong, et al. (+11)
28 [GO] 2024―Feb―05 Lack of association between SARS-CoV-2 PCR positivity and subsequent asthma diagnosis in a pediatric cohort James Senter, Laura Aisenberg, Jesse Dudley, Xianqun Luan, Jing Huang, Chén Kenyon, David Hill
29 [GO] 2024―Feb―05 Wildfire Smoke Exposure during SARS-CoV-2 Vaccination Impairs Immunity via Natural Killer Cell derived IL-13 Gursharan Kaur Sanghar, Melissa Teuber, Resmi Ravindran, Emma Keller, Pedro Hernandez, Sophie Krauss, et al. (+7)
30 [GO] 2024―Feb―05 SARS-CoV-2 Vaccine Response Following Five Total Vaccine Doses in Adult Patients with Predominantly Antibody Deficiency (PAD) AHMED ELMOURSI, Anna Zhang, Daniel Digiacomo, Baijun Zhou, Megha Tandon, Joseph Hong, et al. (+11)
31 [GO] 2023―Dez―27 Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals. Ottavia M. Delmonte, Cihan Oguz, Kerry Dobbs, Katherine Myint-Hpu, Boaz Palterer, Michael S. Abers, et al. (+50)
32 [GO] 2023―Dez―27 Booster doses of COVID-19 vaccine enhance neutralization efficiency against XBB.1.5 Elsa Sakr, Nisha D. Almeida, Marc-Andre Langlois, Kaberi Dasgupta, Bruce D. Mazer
33 [GO] 2023―Okt―28 Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia Joseph M. Rocco, Kristin L. Boswell, Elizabeth Laidlaw, Brian Epling, Megan Anderson, Leonid Serebryannyy, et al. (+11)
34 [GO] 2023―Okt―04 Protective mechanisms of allergic asthma in COVID-19 Naresh Doni Jayavelu, Daniel J. Jackson, Matthew C. Altman
35 [GO] 2023―Sep―21 The SARS-CoV-2 Pandemic and Asthma: What We Have Learned and What is still Unknown Christa McPhee, Kateryna Yevdokimova, Linda Rogers, Monica Kraft
36 [GO] 2023―Aug―16 Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance. Timothy R. O’Meara, Etsuro Nanishi, Marisa E. McGrath, Soumik Barman, Danica Dong, Carly Dillen, et al. (+7)
37 [GO] 2023―Aug―12 Urticaria Exacerbations and Adverse Reactions in Patients with Chronic Urticaria Receiving COVID-19 Vaccination: Results of the UCARE COVAC-CU Study Emek Kocaturk, Pascale Salameh, Esra Sarac, Carolina E. Vera Ayala, Simon Francis Thomsen, Torsten Zuberbier, et al. (+107)
38 [GO] 2023―Jul―10 Causal relationship between asthma-related diseases and the risk of COVID-19: A 2-sample mendelian randomization study Shu Ran, XinHong Qiu, BaoLin Liu
39 [GO] 2023―Jun―07 Updated Guidance Regarding The Risk ofAllergic Reactions to COVID-19 Vaccines and Recommended Evaluation and Management: A GRADE Assessment, and International Consensus Approach Matthew Greenhawt, Timothy E. Dribin, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David BK. Golden, et al. (+88)
40 [GO] 2023―Mai―19 Does pollen exposure influence innate immunity to SARS-CoV-2 in allergy or asthma? Saeideh Hajighasemi, Kirsten Spann, Janet M. Davies
41 [GO] 2023―Mai―11 Trust and Virtual Communication During the COVID pandemic for adults with asthma from low income neighborhoods: What Have We Learned? Andrea J. Apter, Tyra Bryant-Stephens, Hami Park, Heather Klusaritz, Xiaoyan Han, Knashawn H. Morales
42 [GO] 2023―Mrz―29 Type-2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells Naresh Doni Jayavelu, Matthew C. Altman, Basilin Benson, Matthew Dufort, Elizabeth R. Vanderwall, Lucille M. Rich, et al. (+5)
43 [GO] 2023―Feb―24 Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children Giorgia Bucciol, Isabelle Meyts
44 [GO] 2023―Feb―21 COVID-19 induced olfactory loss BA Stuck, S Menzel, M Laudien, CA Hintschich, T Hummel
45 [GO] 2023―Feb―08 SARS-CoV-2 infection of thymus induces loss of function which correlates with disease severity Marco Rosichini, Veronica Bordoni, Domenico Alessandro Silvestris, Davide Mariotti, Giulia Matusali, Antonella Cardinale, et al. (+15)
46 [GO] 2023―Feb―03 Elevated PAI-1 Levels Are Associated With Severe COVID-19 Susumu Fukahori, Jung Yeon Han, Iset Vera, Richard Lockey, Kami Kim, Seong Cho
47 [GO] 2023―Feb―03 Asthma Management Among Children With Food Allergy in the FORWARD Study During COVID-19 Neil Thivalapill, Sai Nimmagadda, Lucy Bilaver, Jialing Jiang, Johnathan Choi, Eirene Fithian, et al. (+18)
48 [GO] 2023―Feb―03 Biologic Treatment For Asthma Decreases Incidence of COVID-19 Sofia Tovar, Alyssa Osheim, Sophia Schultz, Eric Schultz
49 [GO] 2023―Feb―03 Delayed or Forgone Medical Care due to COVID-19 among Adults and Children with Atopic Dermatitis Brian Cheng, Anne Kim
50 [GO] 2023―Feb―03 Discrete T-Cell and Inflammatory Profiles in the Blood Define Pulmonary Phenotypes After COVID-19 Illness. Glenda Canderan, Lyndsey Muehling, Alexandra Kadl, Jeffrey Sturek, Catherine Bonham, Deborah Murphy, et al. (+5)
51 [GO] 2023―Feb―03 The Impact Of COVID-19 In Asthma Control In Patients With Severe Asthma Margarida Gomes, Sara Morgado, Ana Rita Presa, Joana Iap, Ana Mendes, Maria Elisa Pedro
52 [GO] 2023―Feb―03 Rates Of Corticosteroid And Antibiotic Prescriptions Are Significantly Increased With Omicron As Compared To Alpha And Delta Variants Of COVID-19 In Patients With Asthma Elizabeth Kudlaty, Amina Guo, Gayatri Patel, Melissa Watts, Anju Peters
53 [GO] 2023―Feb―03 Description of COVID-19 infection in 92 patients with primary or secondary immunodeficiency followed at the Immunodeficiency Outpatient Clinic of a tertiary hospital Guacira Franco, Natalia Menechino, Larissa Nathalia Lopes, Adriana Pitchon, Fabiana Lima, Ana Karolina Marinho, et al. (+4)
54 [GO] 2023―Feb―03 Safety of COVID-19 vaccines and effect of COVID-19 infection in children with milk allergies Junghyun Kwon, Bruce Mazer, Pasquale Mule, Christine McCusker, Liane Beaudette, Manel Ouamrane, et al. (+3)
55 [GO] 2023―Feb―03 Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies David Sanchez, Lin Radigan, Charlotte Cunningham-Rundles
56 [GO] 2023―Feb―03 High prevalence of autoantibodies in children after COVID-19 infection of differing levels of severity Katherine Konvinse, Natalie Bruiners, Rahul Ukey, Emily Yang, Lawrence Kleinman, Daniel Horton, et al. (+2)
57 [GO] 2023―Feb―03 COVID-19 Infection Outcomes In Inner-City Asthmatics Mydalyn Beronilla, Eryn Fox, Alla Fizitskaya, David Rosenstreich, Golda Hudes
58 [GO] 2023―Feb―03 Allergic Outcomes at 2 years in children born during COVID-19 lockdown: the CORAL study Sadhbh Hurley, Ruth Franklin, Naomi McCallion, John Fitzsimons, Aideen Byrne, Martin White, et al. (+2)
59 [GO] 2023―Feb―03 Delayed Onset of Symptomatic Dermatographism following COVID-19 mRNA Booster Margaret Co
60 [GO] 2023―Feb―03 COVID-19 mRNA Vaccine-induced Immunization Stress-Related Response (ISRR) and Anaphylaxis: An Early Look at COVAAR Clinical Outcomes Muhammad Khalid, Joanna Utoh, Ellen Zektser, Pamela Guerrerio
61 [GO] 2023―Feb―03 Efficacy of a 6-Month Online Market Platform in Addressing Food Insecurity and Supporting Food Allergy Management in Predominantly Spanish-speaking and Low-income communities During the COVID-19 Pandemic Marleni Albarran, Christopher Warren, Sharon Chinthrajah, Crysta Green, Erin Martinez, Emily Brown, et al. (+2)
62 [GO] 2023―Feb―03 Increased telehealth use and reduced severe exacerbations for asthma patients during the COVID-19 pandemic Stephanie Zawada, Jonathan Inselman, Jacob Maddux, Molly Jeffery, Matthew Rank
63 [GO] 2023―Feb―03 Risk Factors for Poor Asthma Control in an Urban Pediatric Population During the COVID-19 Pandemic Abigail Troy, Nathan Huang, Crystal Ajja, Milind Pansare, Pavadee Poowuttikul, Ronald Thomas, Jenny Huang
64 [GO] 2023―Feb―03 Metabolic Syndrome and Pulmonary Dysfunction in Socioeconomically Disadvantaged Asthmatic Children During COVID-19 Pandemic Young Yoo, Minjung Kang, Hanho Kim, Nawon Oh, Seunghyun Kim, Wonsuck Yoon
65 [GO] 2023―Feb―03 A Qualitative Study of the Experiences and Changes in the Daily and Occupational Activities of Allergists and Otolaryngologists due to the COVID-19 Pandemic Elizabeth Garcia, Lucia PEREZ, ADRIANA MARTÍNEZ, SERGIO MORENO, DANIEL PEÑARANDA, GILMA ALDANA, et al. (+4)
66 [GO] 2023―Feb―03 Decreased pollen sensitization in school-age children after the COVID-19 pandemic : COCOA study Kun Baek Song, Min Jee Park, Eom Ji Choi, Eun Young Paek, Sungsu Jung, Jisun Yoon, et al. (+8)
67 [GO] 2023―Feb―03 Local Immune Responses in Placentas of Women with COVID-19 SARS Complicated Pregnancy Increase with Each Trimester Galyna Yeryomenko, Lawrence DuBuske, Myhaylo Myrosnuchenko
68 [GO] 2023―Feb―03 Subacute Onset of Chronic Urticaria Post COVID-19 Vaccination Kristy Semenza
69 [GO] 2023―Feb―03 Cutaneous Adverse Reactions Associated with COVID-19 Vaccination Hope Jin, Luz Fonacier, Jake Rosenblum
70 [GO] 2023―Feb―03 Urticaria After COVID-19 Vaccination and Vaccine Hesitancy Kimberly Blumenthal, Allen Judd, Upeka Samarakoon, Esther Freeman
71 [GO] 2023―Feb―03 Allergy consultation improves uptake of COVID-19 Vaccination in patients with allergy concerns. Hazar Kobayaa, Parteet Sandhu, Rafael Shehata
72 [GO] 2023―Feb―03 Delayed Cutaneous Reactions Following COVID-19 Vaccinations - A Military Cohort Analysis Charles Miller, Catherine Skerrett, James Quinn
73 [GO] 2023―Feb―03 Can COVID-19 vaccinations cause chronic urticaria? Stacey Chu, Andrew Ayars, David Coleman, Dilawar Khokhar
74 [GO] 2023―Feb―03 SARS-CoV-2 Antibody Semi-Quantitative Levels Is Important In The Management Of COVID-19 Vaccinations In Immunodeficiency Disorder Patients. Joseph Chiao, Lili Wan, J. Joanna Yu, Shaobin Hou, Zhu Qian, Jing Yu, et al. (+7)
75 [GO] 2023―Feb―03 Post-Vaccine Evaluation to Assist with Subsequent COVID-19 Vaccine Administration Jake Rosenblum, Erin Banta, Christie Yie, Meredith Akerman
76 [GO] 2023―Feb―03 Development Of A Clinical Predictive Score For Allergic Reactions To COVID-19 Vaccine (AZD1222) Karnsinee Thanborisutkul, Patcharaporn Punyashthira, Sira Nantapisal, Orapan Poachanukoon, Phichayut Phinyo, Prapasri Kulalert
77 [GO] 2023―Feb―03 Phenotypic distribution and tolerability of re-vaccination in individuals with delayed hypersensitivity to COVID-19 vaccines Joseph De Luca, Andrew Awad, Sara Vogrin, Jamie Waldron, Abby Douglas, Kyra Chua, et al. (+2)
78 [GO] 2023―Feb―03 Immune Responses Of CVID Patients To COVID-19 Vaccines Giuliana Xavier de Medeiros, Loisi de Carvalho Pereira Ferreira, Jhosiene Yukari Magawa, Andréia Kuramoto, Greyce Luri Sasahara, Marcelo Ferreira, et al. (+6)
79 [GO] 2023―Feb―03 Events Supposedly Attributable to Vaccination or Immunization after COVID-19 vaccines in children. Larissa Nathalia Lopes, Natalia Menechino, Jorge Kalil, Ana Karolina Marinho
80 [GO] 2023―Feb―03 Manifestations of Covid-19-associated ANCA-vasculitis Khrystyna Lishchuk-Yakymovych, Iryna Vozniak, Roman Pukalyak, Omelyan Synenkyy, Lawrence DuBuske, Valentyna Chopyak
81 [GO] 2023―Feb―03 Macrophage and Neutrophil Dysregulation are Associated with Persistent COVID-19-induced Olfactory Dysfunction Dante Minichetti, Amelia Boyd, Jonathan Hacker, Caitlin Wong, Evan Lemire, Kathleen Buchheit, et al. (+4)
82 [GO] 2023―Feb―03 Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency Megha Tandon, Daniel DiGiacomo, Chen Rosenberg, Paul Hesterberg, Sara Barmettler, Jocelyn Farmer
83 [GO] 2023―Feb―03 Kinetics of Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Doses in Patients With Predominant Antibody Deficiency Daniel DiGiacomo, Megha Tandon, Baijun Zhou, Jocelyn Farmer, Sara Barmettler
84 [GO] 2023―Feb―03 Immunoglobulin-A,G,M Antibody Responses Over Time to Four Severe-Acute-Respiratory Coronavirus Proteins Following First and Second mRNA Vaccination. Alyssa Burrows, Jenny Thiele, Sophia Linton, Lubnaa Hossenbaccus, Prameet Sheth, Stephen Vanner, Anne Ellis
85 [GO] 2023―Feb―03 Blood albumin:globulin levels are associated with comorbidity index and predicted survival in Coronavirus-19 Shawn Mathew, Sairaman Nagarajan, Tamar Smith-Norowitz, Mansi Kothari, Rauno Joks
86 [GO] 2023―Feb―03 TLR4 Expression on Neutrophils and Peripheral Blood Monocytes in Patients with Acute SARS-COV-2 Igor Yatskov, Vladimir Beloglazov, Lawrence DuBuske
87 [GO] 2023―Feb―03 Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron Daniel O’Shea, Charles Schuler, Jesse Chen, Jonathan Troost, Pamela Wong, Kelsea Chen, et al. (+7)
88 [GO] 2023―Feb―03 Viral Neutralization Against SARS-CoV-2 is More Durable After Infection Versus Vaccination Kelsea Chen, Kelly O'Shea, Charles Schuler, Jesse Chen, Jonathan Troost, Pamela Wong, et al. (+7)
89 [GO] 2023―Feb―03 Enhanced Medical Support for Primary Immunodeficiency Disorders (PIDD): A Patient-guided Intervention to Ensure Patient Engagement During a Global Pandemic and Beyond Kathleen Sullivan, Pam McFadden, Steve Folstein, Monica Augustyniak, John Boyle, Victoria Dimitriades, et al. (+9)
90 [GO] 2023―Feb―03 Characterization of SCIT Induced Anaphylaxis Pre and Post Pandemic: Did COVID Make An Impact? Anna Oprea, Jason Ohayon
91 [GO] 2023―Feb―02 Phospholipid remodeling and its derivatives are associated with the severity of COVID-19 Juntong Wei, Xiaoyu Liu, Weimin Xiao, Jiahua Lu, Li Guan, Zhangfu Fang, et al. (+10)
92 [GO] 2022―Dez―13 Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity Stuart G. Tangye
93 [GO] 2022―Dez―10 NFKB2 haploinsufficiency identified via screening for IFNα2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications Aaron Bodansky, Sara E. Vazquez, Janet Chou, Tanya Novak, Amer Al-Musa, Cameron Young, et al. (+35)
94 [GO] 2022―Nov―03 Comorbidity defines risk of asthmatics for COVID-19 hospitalization: a global perspective Chrysanthi Skevaki, R. Sharon Chinthrajah, Daria Fomina, Gernot Rohde, Shu Cao, Ziyuan He, et al. (+10)
95 [GO] 2022―Sep―13 Genetic and immunological evaluation of children with inborn errors of immunity and severe or critical COVID-19 Hassan Abolhassani, Samaneh Delavari, Nils Landegren, Sima Shokri, Paul Bastard, Likun Du, et al. (+17)
96 [GO] 2022―Jul―14 Angiotensin II induces reactive oxygen species, DNA damage, and T cell apoptosis in severe COVID-19 Lucy Kundura, Sandrine Gimenez, Renaud Cezar, Sonia André, Mehwish Younas, Yea-Lih Lin, et al. (+17)
97 [GO] 2022―Jul―11 Spontaneous NLRP3 inflammasome-driven IL1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment Arinna Bertoni, Federica Penco, Hilaria Mollica, Paola Bocca, Ignazia Prigione, Anna Corcione, et al. (+18)
98 [GO] 2022―Jun―16 Pre-existing comorbidities shape the immune response associated with severe COVID-19 Stefanie Kreutmair, Manuel Kauffmann, Susanne Unger, Florian Ingelfinger, Nicolás Gonzalo Núñez, Chiara Alberti, et al. (+20)
99 [GO] 2022―Jun―01 Risk factors for SARS-CoV-2 infection and transmission in households with asthmatic and allergic children. A prospective surveillance study Max A. Seibold, Camille M. Moore, Jamie L. Everman, Blake J.M. Williams, James D. Nolin, Ana Fairbanks-Mahnke, et al. (+29)
100 [GO] 2022―Mai―24 Current vaccine strategies against SARS-CoV-2: Promises and challenges Drishya Kurup, Jacob Myers, Matthias J. Schnell
101 [GO] 2022―Mai―12 SARS-CoV-2 vaccination in the immunocompromised host Caoilfhionn M. Connolly, Julie J. Paik
102 [GO] 2022―Apr―22 The arrival of SARS-CoV-2-neutralizing antibodies in a currently available commercial immunoglobulin Aaron L. Miller, Nicholas L. Rider, Richard B. Pyles, Barbara Judy, Xuping Xie, Pei-Yong Shi, Thomas G. Ksiazek
103 [GO] 2022―Apr―11 Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity Leanne P.M. van Leeuwen, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, Godelieve J. de Bree, Judith Potjewijd, Abraham Rutgers, et al. (+31)
104 [GO] 2022―Apr―07 Rapid Progress in Our Understanding of Covid-19 Vaccine Allergy: A Cause for Optimism, not Hesitancy Aleena Banerji, Allison E. Norton, Kimberly G. Blumenthal, Cosby A. Stone, Elizabeth Phillips
105 [GO] 2022―Feb―01 Tocilizumab: History and Future Perspectives in the Era of COVID-19 Rina Modha, Stuart Novack
106 [GO] 2022―Feb―01 Factors Leading to Reduced Unscheduled Pediatric Asthma Visits During COVID-19 Sean Stout, Aarti Pandya, Helen Murphy, Hung-Wen Yeh, Jay Portnoy
107 [GO] 2022―Feb―01 Influenza vaccination patterns in an Allergy specialty clinic during COVID-19 Jackson Massanelli, Robbie Pesek, Amika Sood, Kim Cobb, Stacie Jones
108 [GO] 2022―Feb―01 Impact of Asthma, COPD, and ACO on the Prognosis of COVID-19 Eunyong Shin, Juhae Jin, Seo Young Park, Young sang Yoo, Ji-Hyang Lee, Jin An, et al. (+6)
109 [GO] 2022―Feb―01 New onset of autoimmune diseases in patients with primary antibody deficiency and CD4 lymphopenia after COVID-19 Elena Zidan, Junghee Shin
110 [GO] 2022―Feb―01 COVID-19 Concerns, Resilient Coping, and Socioeconomic Burden among Asthmatic Adults Alexander Schuyler, Merritt Fajt, Courtney Elvin, Sally Wenzel
111 [GO] 2022―Feb―01 Charlson Comorbidity Index and National Early Warning Score 2: Predictors of Mortality in COVID-19 Hospitalizations Mariam Majzoub, Rauno Joks
112 [GO] 2022―Feb―01 Antibody Production After COVID-19 Immunization In Patients With Primary Immunodeficiency: A Single Center Experience Hannie Zomer Bolanos, Mohamed Ebrahim, Arye Rubinstein
113 [GO] 2022―Feb―01 Clinical Outcomes of COVID-19 in Common Variable Immunodeficiency Patients Derek Nye, Lauren Kaminsky, Taha Al-Shaikhly
114 [GO] 2022―Feb―01 Covid-19 in outpatient and inpatient Asthmatics in Lebanon: Real-life experience Carla Irani, Mariam Chalhoub, Elie Ghayad
115 [GO] 2022―Feb―01 Retrospective Analysis Of COVID-19 Incidence And Health Outcomes Among Patients With Asthma In A Large Integrated Health Care Delivery System Lindsay Finkas, Lawrence Block, Meng Lu, Bing Yu, Mei Lee, Carlos Iribarren
116 [GO] 2022―Feb―01 Allergic Asthma Patients Experience Lower Rates of Asthma Exacerbation Compared to Non-Allergic Asthma Patients Following COVID-19 Infection Rishi Jaswaney, Katharine Foster, Donyea Moore, Aame Andy-Nweye, Mahboobeh Mahdavinia
117 [GO] 2022―Feb―01 COVID-19 Infection Outcomes in Inner City Asthmatics Treated with Biologics Golda Hudes, Mydalyn Beronilla, Denisa Ferastraoaru, Elina Jerschow, Manish Ramesh, Alla Fizitskaya, David Rosenstreich
118 [GO] 2022―Feb―01 Monoclonal antibody infusion for COVID-19 infection: results from a tertiary referral center Dayne Voelker, Maya Jerath
119 [GO] 2022―Feb―01 Vaccination against COVID-19 Leads to Enhanced Immunity Despite Infection History Kelly O'Shea, Charles Schuler, Carmen Gherasim, David Manthei, Jesse Chen, Cristyn Zettel, et al. (+7)
120 [GO] 2022―Feb―01 Difficult to Control Asthma During COVID-19 Lockdown Hiroshi Chantaphakul, Pongsawat Rodsaward, Pattarawat Thantiworasit, Palita Rodanant, Natthiya Pholmoo, Jettanong Klaewsongkram
121 [GO] 2022―Feb―01 Allergy Outcomes at 12 months in children born during COVID-19 lockdown : the CORAL study Sadhbh Hurley, Ruth Franklin, Marguerite Lawler, Naomi McCallion, John Fitzsimons, Aideen Byrne, et al. (+3)
122 [GO] 2022―Feb―01 Association Between IgE Levels and COVID-19 Mortality Yasmine Oprea, Denisa Ferastraoaru
123 [GO] 2022―Feb―01 COVID-19 mRNA Vaccination Appears Safe in Pediatric Patients With A Hypersensitivity Reaction To PEGylated Escherichia Coli L-Asparaginase Nicole Wolfset, Charles Phillips, Madison Stein, Susan Rheingold, Jennifer Heimall, Caitlin Elgarten
124 [GO] 2022―Feb―01 Risk factors associated with treated acute-onset hypersensitivity reactions after COVID-19 mRNA vaccinations Shalin Pandya, Eric Macy, William Crawford, Amber Burnette, Javed Sheikh, Jiaxiao Shi, et al. (+3)
125 [GO] 2022―Feb―01 The Effect of COVID-19 on The September Asthma Peak Jessica Hollenbach, Melanie Collins, Michael Brimacombe, Alexander Hogan
126 [GO] 2022―Feb―01 Eosinophilia is Associated with Improved COVID-19 Outcomes in Patients Treated with Inhaled Corticosteroids Ronald Strauss, Joe Zein, Amy Attaway, Alex Milinovich, Nesreen Jawhari, Soulaima Chamat, Victor Ortega
127 [GO] 2022―Feb―01 Changes in remote care adoption for asthma during the COVID-19 pandemic Leanne Kaye, Vy Vuong, Meredith Barrett
128 [GO] 2022―Feb―01 A Multicenter Assessment of Food Allergy Quality of Life in Adolescents and Caregivers in Relation to Anxiety and Depression during the COVID-19 Pandemic Naiya Patel, Layla Samandi, Adam Price, Ashton Rogers, Emily Seminara, Brandi Whitaker, et al. (+8)
129 [GO] 2022―Feb―01 A Multi-Center Evaluation of Anxiety, Depression, and Resilience in Food Allergic Adolescents and Primary Caregivers during the COVID-19 Pandemic Adam Price, Amy Scurlock, Ashton Rogers, Emily Seminara, Naiya Patel, Stacie Jones, et al. (+8)
130 [GO] 2022―Feb―01 Food and Housing Insecurity and its Effect on Asthma Control During the Covid-19 Pandemic Matthew Grande, Kamal Eldeirawi, Barbara Polivka, Luz Huntington-Moskos, Sharmilee Nyenhuis
131 [GO] 2022―Feb―01 Childhood Allergy and the NeOnatal Environment (CANOE) Research Protocol and Recruitment Redesign during the COVID-19 Pandemic Tonia Afshan, Ajit Kulkarni, Talissa Blackshere, Jennifer Smith, Elizabeth Tesson, Tina Hartert, et al. (+5)
132 [GO] 2022―Feb―01 Housing Conditions and Access to Care for Children with Asthma During COVID-19 Pandemic in New York City Kaoru Harada, Erin Thanik, Nicholas DeFelice, Jasmine Bhatia, Ray Lopez, Sergio Galvez, et al. (+4)
133 [GO] 2022―Feb―01 Effects Of The COVID-19 Pandemic On A Group Of Patients With Pathogenic Variant of Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA-4) in a Tertiary Center in Florida Priyanka Timothy, Peter Illes, Boglarka Ujhazi, Sumai Gordon, Bence Nagy, Eugenia Alas, et al. (+10)
134 [GO] 2022―Feb―01 The Impact of the COVID-19 Pandemic on Food Allergy Families Melissa Hearrell, Xiaofan Huang, Kristen Staggers, Carla Davis
135 [GO] 2022―Feb―01 Outcomes for COVID-19 Patients with Asthma at a Tertiary Care Center Kavitha Thiagarajan, Maryam Masood, Xinyu Wang, Rose Monahan, Kenny Kwong
136 [GO] 2022―Feb―01 Asthma Severity and COVID-19 Related Hospitalizations Nurbek Mambetsariev, Michael Chen, Gayatri Patel, Paul Greenberger, Bruce Bochner, Leslie Grammer, et al. (+3)
137 [GO] 2022―Feb―01 Impact of COVID-19 Restrictions on Anaphylaxis Presentations to the Emergency Department Jordan Trevisonno, Kevin Zhao, Adnan Al Ali, Sofianne Gabrielli, Ann Clarke, Judy Morris, et al. (+16)
138 [GO] 2022―Feb―01 Improving Mobile Health for Asthma in a Pandemic: Patient Use of an Integrated COVID-19 Screener Dinah Foer, Jorge Sulca Flores, David Bates, Anuj Dalal, Robert Rudin
139 [GO] 2022―Feb―01 Eosinopenia And COVID-19 Severity: Is There A Relationship? Margarida Gomes, Marisa Paulino, António Lacerda, Ana Mendes, M Elisa Pedro
140 [GO] 2022―Feb―01 Clinical characteristics of subjects with lack of seroconversion following COVID-19 vaccination Vaibhav Ahluwalia, Vivek Iyer, Sarah Jenkins, Carin Smith, Elitza Theel, Tanmay Iyer, et al. (+2)
141 [GO] 2022―Feb―01 Predictors Of Seroconversion Following COVID-19 Vaccination Sergio Chiarella, Sarah Jenkins, Carin Smith, Vaibhav Ahluwalia, Vikas Prasad, Vivek Iyer, et al. (+2)
142 [GO] 2022―Feb―01 Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination Alexa Doss, Rita Chen, Jennifer Monroy, H. James Wedner, Anthony Kulczycki, Tiffany Dy, et al. (+8)
143 [GO] 2022―Feb―01 Self-Reported Reactions After COVID-19 Vaccination Allen Judd, Upeka Samarakoon, Kimberly Blumenthal
144 [GO] 2022―Feb―01 Patients with Pseudoallergic Reactions Following COVID-19 Vaccination are Able to Tolerate Subsequent Dosing Alexander Patterson, Peggy Kendall, Jennifer Monroy, Christine Pham, Zhen Ren, Maya Jerath
145 [GO] 2022―Feb―01 Urticarial and Eczematous Eruptions Following mRNA COVID-19 Vaccination in Patients With and Without Chronic Urticaria and Atopic Dermatitis Ruchi Shah, Lulu Tsao, Jessica Zheng, Monica Tang, Iris Otani
146 [GO] 2022―Feb―01 COVID-19 Vaccination in Patients with Documented Reactions to Polyethylene Glycol or Polysorbate Monica Tang, Lulu Tsao, Iris Otani
147 [GO] 2022―Feb―01 Tolerability of COVID-19 Vaccination in Patients with Mast Cell Activation Jessica Macdougall, Claire Amelio, Mildred Kwan, Onyinye Iweala
148 [GO] 2022―Feb―01 COVID-19 Vaccination in Pediatric Patients with History of Allergic Reactions Cristina Vo, Magee DeFelice
149 [GO] 2022―Feb―01 Multidisciplinary Institutional Practice Plan to Safely Administer COVID-19 Vaccination to Health Center Employees Andrew Rorie
150 [GO] 2022―Feb―01 Anaphylaxis After COVID-19 Vaccination: A Registry-Based Study Jordon Jaggers, Upeka Samarakoon, Xiaoqing Fu, Alexei Gonzalez-Estrada, Sara Anvari, Shwetabh Tarun, et al. (+7)
151 [GO] 2022―Feb―01 Urticaria and/or angioedema events secondary to mRNA COVID-19 vaccinations - Updates from a national case registry Sara Anvari, Upeka Samarakoon, Xiaoqing Fu, Jordon Jaggers, Alexei Gonzalez-Estrada, Hey Jin Chong, et al. (+6)
152 [GO] 2022―Feb―01 Allergic and Nonallergic Covid-19 Vaccine Adverse Reactions in Hospital Employees Hope Jin, Althea Marie Diaz, Michael Phillips, Meredith Akerman, Carol Cohan, Steven Salvati, et al. (+2)
153 [GO] 2022―Feb―01 Outcomes from New Consultations to Allergy Clinic for COVID-19 Vaccine Concerns Samuel Boderman, Sujani Kakumanu, Ravi Viswanathan, Daniel Rosenberg, Mark Moss, Sameer Mathur
154 [GO] 2022―Feb―01 Prevalence of α-Gal IgE and Mammalian Meat Allergy in a COVID-19 Vaccine Employee Cohort Nathan Richards, Behnam Keshavarz, Lisa Workman, Jaimin Patel, Thomas Platts-Mills, Jeffrey Wilson
155 [GO] 2022―Feb―01 COVID-19 Vaccine Induced Flares of Chronic Spontaneous Urticaria: A Case Series Madeleine Smee, Mina Abbaslou, Gordon Sussman, Stephanie Brooks, Anna De Jong
156 [GO] 2022―Feb―01 Survivors Of Severe COVID-19 With Long-Haul Respiratory Symptoms Display Enhanced Activation of Circulating T Cells Glenda Canderan, Lyndsey Muehling, Alexandra Kadl, Chintan Ramani, Jeffrey Sturek, Cathy Bonham, et al. (+7)
157 [GO] 2022―Feb―01 Spike Antibody Assays Can Screen For Viral Neutralizing Activity Toward SARS-CoV-2 Charles Schuler, Kelly O'Shea, Carmen Gherasim, David Manthei, Jesse Chen, Cristyn Zettel, et al. (+7)
158 [GO] 2022―Feb―01 SARS-CoV-2 and Perceived Physical, Mental and Social Health in Northern California Katharine Fast, Alexandra Lee, Quinlan Hampton, Sharon Chinthrajah, Sayantani Sindher, Xiaolin Jia, et al. (+3)
159 [GO] 2022―Feb―01 SARS-CoV-2 Antibody Profile of Immune Globulin Preparations Hyun Park, Satyen Gada
160 [GO] 2022―Feb―01 SDRIFE-like reaction with systemic affectation after SARS-COV-2 infection Maria del Valle Campanón-Toro, Aida Gómez-Cardeñosa, Alicia Gallardo-Higueras, Esther Moreno-Rodilla
161 [GO] 2022―Feb―01 Exhaled nitric oxide is decreased in Sars-Cov-2 infection Diana Betancor, Marcela Valverde Monge, Blanca Barroso GarcÃa, Joaquin Sastre
162 [GO] 2022―Feb―01 The Humoral Immune Response To SARS-CoV-2 Infection And/or Immunization in Immunocompromised Versus Immunocompetent Individuals Peter Illes, Krisztian Csomos, Boglarka Ujhazi, Joseph Dasso, Bence Nagy, Eugenia Alas, et al. (+7)
163 [GO] 2022―Feb―01 Cathepsin G in Patients with SARS-Cov-2 Infection of Various Degrees of Severity Vladimir Beloglazov, Igor Yatskov, A. Nikolaeva, E. Lavrenchuk, Lawrence DuBuske
164 [GO] 2022―Feb―01 Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma Anam Ashraf, Mohamed Eslam, Weyman Lam, Andrew Avila
165 [GO] 2022―Feb―01 SARS-CoV-2 surveillance in households with and without asthmatic/allergic children: The Human Epidemiology and Response to SARS-CoV-2 study (HEROS) Max Seibold, Camille Moore, Jamie Everman, Blake Williams, James Nolin, Ana Fairbanks-Mahnke, et al. (+29)
166 [GO] 2022―Feb―01 T Cell Responses to SARS-CoV-2 Vaccination and Infection in Antibody Deficiency Diseases Alex Wonnaparhown, Alan Curtis, Bernard Fischer, Guglielmo Venturi, Jolan Walter, Teresa Tarrant, et al. (+2)
167 [GO] 2022―Feb―01 Increasing SARS-CoV-2 Vaccine Counseling by Fellows in the Allergy Clinic Basil Kahwash, Kristen Corey
168 [GO] 2022―Feb―01 Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro Andrei Hancharou, N. Antonevich, T. Pozniak, Darya Babrukevich, P. Semizhon, E. Scheslenok, et al. (+4)
169 [GO] 2022―Feb―01 Reduced SARS-CoV-2 Vaccine Response in Patients Treated with Biologic Therapies for Asthma and Atopic Dermatitis Martin Runnstrom, Andrea Morrison-Porter, Mayuran Ravindran, Hannah Quehl, Richard Ramonell, Matthew Woodruff, et al. (+15)
170 [GO] 2022―Feb―01 Interleukin-2: An Accurate Biomarker for Rapid Testing of SARS-CoV-2 Vaccine-induced T cell Immune Responses in Whole Blood Maria Oliver, Bryan Smith, Nicole Brackett
171 [GO] 2022―Feb―01 SARS-CoV-2-specific T Cell Immunity after Vaccination with Sputnik V and BBIBP-CorV Darya Babrukevich, N. Antonevich, Andrei Hancharou, A. Rynda, O. Timohina, Y. Minich, et al. (+2)
172 [GO] 2022―Feb―01 Regular Use of Nasally Applied Methyl-cellulose Powder During the Pollen Season Protects Against Sars-Covid-2 Infections Todor Popov, Peter Josling, Lawrence DuBuske
173 [GO] 2022―Feb―01 Addressing Food Insecurity and Improving Food Allergy Management among Pediatric Patient/Caregiver Dyads During the COVID Pandemic Marleni Albarran, Christopher Warren, Sharon Chinthrajah, Erin Martinez, Lauren Casareno, Alyssa Rodriguez, et al. (+4)
174 [GO] 2022―Jan―29 Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern Eliott Lafon, Michael Jäger, Angelika Bauer, Markus Reindl, Rosa Bellmann-Weiler, Doris Wilflingseder, et al. (+2)
175 [GO] 2022―Jan―21 Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19 convalescent individuals Min Li, Jiaojiao Liu, Renfei Lu, Yuchao Zhang, Meng Du, Man Xing, et al. (+8)
176 [GO] 2022―Jan―17 Profiling natural killers in COVID-19 Emily M. Mace
177 [GO] 2021―Dez―24 Advances in clinical outcomes: what we have learned during the COVID-19 pandemic Amer Al-Musa, Brenna LaBere, Saddiq Habiballah, Alan A. Nguyen, Janet Chou
178 [GO] 2021―Dez―21 Asthma and Atopy in COVID-19: 2021 Updates Tara F. Carr, Monica Kraft
179 [GO] 2021―Dez―21 Immunogenicity and Tolerability of COVID-19 mRNA Vaccines in PID patients with functional B-cell defects Michele N. Pham, Kanagavel Murugesan, Niaz Banaei, Benjamin A. Pinsky, Monica Tang, Elisabeth Hoyte, et al. (+2)
180 [GO] 2021―Dez―10 The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression Vadim Pivniouk, Oksana Pivniouk, Avery DeVries, Jennifer L. Uhrlaub, Ashley Michael, Denis Pivniouk, et al. (+10)
181 [GO] 2021―Nov―24 The COVID-19 as an infectome paradigm of autoimmunity Arad Dotan, Naim Mahroum, Dimitrios P. Bogdanos, Yehuda Shoenfeld
182 [GO] 2021―Nov―17 Severe COVID-19 is associated with hyperactivation of the alternative complement pathway Jeremy Boussier, Nader Yatim, Armance Marchal, Jérôme Hadjadj, Bruno Charbit, Carine El Sissy, et al. (+11)
183 [GO] 2021―Nov―12 Treatment of chronic or relapsing COVID-19 in immunodeficiency Li-An K. Brown, Ed Moran, Anna Goodman, Helen Baxendale, William Bermingham, Matthew Buckland, et al. (+16)
184 [GO] 2021―Nov―02 Immune Health Grades: Finding Resilience in the COVID-19 Pandemic and Beyond Vincent C. Marconi, Venkatesh Krishnan, E. Wesley Ely, Monty Montano
185 [GO] 2021―Okt―25 SARS-CoV-2 specific B- and T-cell immunity in a population-based study of young Swedish adults Sophia Björkander, Likun Du, Fanglei Zuo, Sandra Ekström, Yating Wang, Hui Wan, et al. (+11)
186 [GO] 2021―Okt―20 Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency Ane Fernandez Salinas, Eva Piano Mortari, Sara Terreri, Cinzia Milito, Salvatore Zaffina, Carlo Federico Perno, et al. (+3)
187 [GO] 2021―Sep―24 COVID-19, Health Disparities, and What the Allergist-Immunologist Can Do Princess U. Ogbogu, Elizabeth C. Matsui, Andrea J. Apter
188 [GO] 2021―Sep―15 Immunological memory to SARS-CoV-2 in convalescent COVID-19 patients at one-year post-infection Hongyan Hou, Yandi Zhang, Guoxing Tang, Ying Luo, Wei Liu, Chang Cheng, et al. (+7)
189 [GO] 2021―Sep―14 Occupational Health Disparities: The Pandemic as Prism and Prod Emily Brigham, Drew Harris, Christopher Carlsten, Carrie A. Redlich
190 [GO] 2021―Sep―08 Immunologic resilience and COVID-19 survival advantage Grace C. Lee, Marcos I. Restrepo, Nathan Harper, Muthu Saravanan Manoharan, Alisha M. Smith, Justin A. Meunier, et al. (+34)
191 [GO] 2021―Sep―04 Antibody responses to the SARS-CoV-2 vaccine in individuals with various Inborn Errors of Immunity Ottavia M. Delmonte, Jenna R.E. Bergerson, Peter D. Burbelo, Jessica R. Durkee-Shock, Kerry Dobbs, Marita Bosticardo, et al. (+22)
192 [GO] 2021―Jul―31 Abnormality in the NK cell population is prolonged in severe COVID-19 patients Galam Leem, Shinhye Cheon, Hoyoung Lee, Seong Jin Choi, Seongju Jeong, Eui-Soon Kim, et al. (+5)
193 [GO] 2021―Jul―24 Maternal COVID-19 disease, vaccination safety in pregnancy, and evidence of protective immunity Amelie Pham, David M. Aronoff, Jennifer L. Thompson
194 [GO] 2021―Jul―17 SARS-CoV-2-infected primary human airway epithelia illustrate mucus hypersecretion Wilfried Posch, Cornelia Lass-Flörl, Doris Wilflingseder
195 [GO] 2021―Jul―15 Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination Mary M. Tomayko, William Damsky, Ramie Fathy, Devon E. McMahon, Noel Turner, Monica N. Valentin, et al. (+4)
196 [GO] 2021―Jun―15 COVID-19 risk and outcomes in adult asthmatics treated with biologics or systemic corticosteroids : nationwide real-world evidence Yochai Adir, Marc Humbert, Walid Saliba
197 [GO] 2021―Jun―07 Chemokines and Eicosanoids Fuel the Hyperinflammation Within the Lungs of Patients with Severe COVID-19 Younes Zaid, Étienne Doré, Isabelle Dubuc, Anne-Sophie Archambault, Olivier Flamand, Michel Laviolette, et al. (+3)
198 [GO] 2021―Jun―01 Immunogenicity of Pfizer-BioNTech COVID-19 Vaccine in Patients with Inborn Errors of Immunity. David Hagin, Tal Freund, Michal Navon, Tami Halperin, Dikla Adir, Rotem Marom, et al. (+4)
199 [GO] 2021―Apr―22 Distinct cytokine profiles associated with COVID-19 severity and mortality Karim Dorgham, Paul Quentric, Mehmet Gökkaya, Stéphane Marot, Christophe Parizot, Delphine Sauce, et al. (+19)
200 [GO] 2021―Apr―21 Potential Mechanisms of Anaphylaxis to COVID-19 mRNA Vaccines Kimberly A. Risma, Kathryn M. Edwards, Donna S. Hummell, Frederic F. Little, Allison E. Norton, Amy Stallings, et al. (+2)
201 [GO] 2021―Apr―21 C5aR inhibition of non-immune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia Wilfried Posch, Jonathan Vosper, Asma Noureen, Viktoria Zaderer, Christina Witting, Giulia Bertacchi, et al. (+7)
202 [GO] 2021―Apr―17 Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis Andri Lemarquis, Tessa Campbell, Maribel Aranda-Guillén, Viktoria Hennings, Petter Brodin, Olle Kämpe, et al. (+8)
203 [GO] 2021―Mrz―14 Asthma and viruses (a focus on rhinoviruses and SARS-CoV-2) Yorissa Padayachee, Tasnim Shahridan Faiez, Aran Singanayagam, Patrick Mallia, Sebastian Lennox Johnston
204 [GO] 2021―Mrz―01 Interleukin-6-based mortality prediction model for COVID-19: validation and update in multicentre and second wave cohorts Alberto Utrero-Rico, Javier Ruiz-Hornillos, Cecilia González-Cuadrado, Claudia Geraldine Rita, Berta Almoguera, Pablo Minguez, et al. (+11)
205 [GO] 2021―Feb―09 SARS-CoV-2 Infection and Viral Load are Associated with the Upper Respiratory Tract Microbiome Christian Rosas-Salazar, Kyle S. Kimura, Meghan H. Shilts, Britton A. Strickland, Michael H. Freeman, Bronson C. Wessinger, et al. (+5)
206 [GO] 2021―Feb―06 Efficacy of early anti-inflammatory treatment with high doses IV Anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia Emanuele Pontali, Stefano Volpi, Alessio Signori, Giancarlo Antonucci, Marco Castellaneta, Davide Buzzi, et al. (+17)
207 [GO] 2021―Feb―01 Rapid Adoption of Video Visits and Return-to-Clinic Procedures to Maintain Access to Allergy/Immunology Care Delivery During COVID-19 Lulu Tsao, Stephanie Anne Villanueva Ferraris, David Pines, Eugene Choo, Michele Pham, Monica Tang, et al. (+5)
208 [GO] 2021―Feb―01 Clinical conditions of patients with chronic urticaria during the pandemic caused by the 2019 Novel Coronavirus Disease (COVID-19) Paula Argolo, Grazielly Pereira, G.F. Pereira, Jorge Kalil, Antonio Motta, Rosana Agondi
209 [GO] 2021―Feb―01 Attitudes Among Faculty Members and Trainees About the Effects of Telemedicine on Clinical Education During COVID-19 Patrick Gleeson, Di Sun, Jennifer Heimall, Olajumoke Fadugba
210 [GO] 2021―Feb―01 Phase 1 Randomized Placebo-Controlled Study in Healthy Adult Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate - A Potential Treatment for COVID-19 Ohad Bentur, Richard Hutt, Donna Brassil, Per Bäckman, Igor Gonda, Homer Boushey, et al. (+3)
211 [GO] 2021―Feb―01 Associations of Asthma, COPD and Medication History with the Risk of Severe COVID-19 Brian Huang, Zhanghua Chen, Margo Sidell, Sandrah Eckel, Mayra Martinez, Fred Lurmann, et al. (+3)
212 [GO] 2021―Feb―01 Loss of sense of smells associated with sour taste is a possible diagnostic marker for COVID-19 Mohammad Asad, Esha Sehanobish, Valerie Fong, Meaghan O'Neill, Viraj Patel, Danielle Bottalico, et al. (+13)
213 [GO] 2021―Feb―01 Intravenous Immunoglobulin for Treatment of Severe Coronavirus Disease 19 (COVID-19) - A Literature Overview Syed Rizvi, Huub Kreuwel
214 [GO] 2021―Feb―01 Five-month Outcomes for Asthmatics with COVID-19 and Associations with Atopy and Inhaled Corticosteroids Use Katharine Foster, Donyea Moore, Emilio Jauregui, Aame Andy-Nweye, Mahboobeh Mahdavinia
215 [GO] 2021―Feb―01 COVID-19 and Common Variable Immunodeficiency Marina Kaminski, Gabriela Yoshimoto, Luiza Silva, Ana Garcia, Natasha Ferraroni
216 [GO] 2021―Feb―01 Point-of-care assays can detect COVID-19 antibodies via serum or whole blood Charles Schuler, James Baldwin, James Baker
217 [GO] 2021―Feb―01 Blood Dendritic Cells, Monocytes and Myeloid-derived Suppressor Cells in Patients with COVID-19 Associated Pneumonia Andrei Hancharou, Alena Rynda, Yana Minich, Natalia Antonevich, Oxana Timohina, Alena Halavach, et al. (+4)
218 [GO] 2021―Feb―01 Undiagnosed, familial cold auto-inflammatory syndrome (FCAS) masquerading as COVID-19 cytokine storm Dilawar Khokhar, James Baker
219 [GO] 2021―Feb―01 Immune Predictors of Death versus Survival in COVID-19 ICU Pneumonia Patients on Mechanical Ventilators Natalia Antonevich, Andrei Hancharou, Alena Rynda, Marina Dotsenko, Eduard Dotsenko, Alena Halavach, et al. (+4)
220 [GO] 2021―Feb―01 COVID-19 Impact on Participant Engagement with a School-centered Asthma Navigator Program Melanie Gleason, Arthur McFarlane, Mfonobong Udoko, Elizabeth Konon, Stanley Szefler
221 [GO] 2021―Feb―01 Risk Factors for Mortality from COVID-19 in a New York Inner city Epicenter Mariam Majzoub, Rauno Joks
222 [GO] 2021―Feb―01 A Case of Mild COVID-19 in a Teenager with Common Variable Immunodeficiency and Granulomatous Interstitial Lung Disease on Replacement Immunoglobulin and Infliximab Yatyng Chang, Daniel Urschel, Vivian Hernandez-Trujillo, Jose Calderon
223 [GO] 2021―Feb―01 Analysis Of COVID-19 In Adult Asthmatic Outpatients Maria Somoza Alvarez, Ana MarÃa Prieto-Moreno Pfeifer, Isabel Torres Rojas, Maria Desamparados Cervera, Diana Perez-Alzate, Maria Vazquez de La Torre, et al. (+5)
224 [GO] 2021―Feb―01 Multi-system Inflammatory syndrome in Children (MIS-C): an evolving presentation of COVID-19 in the pediatric population: A Florida State experience and our management approach Farida Karim, Miry Makebish, Pallavi Agarwal, Callah Antonetti
225 [GO] 2021―Feb―01 DiGeorge Syndrome and COVID-19 in Two Pediatric Patients Eilaf Fallatah, Yatyng Chang, Jose Calderon, Vivian Hernandez- Trujillo
226 [GO] 2021―Feb―01 A Survey of Respiratory Symptoms Reported in Patients Following Hospitalization with COVID-19 Infection Eevar B. Rossavik, Zain Iftikhar, Iftikhar Hussain
227 [GO] 2021―Feb―01 Asthma as a predictor of more severe outcomes in COVID-19 infection Lauren Eggert, Shu Cao, Ziyuan He, Gopal Krishna Dhondalay, Shirley Jiang, William Collins, et al. (+3)
228 [GO] 2021―Feb―01 Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. Ijaz Ogeer, Wardha. Wardha, Vaidehi Bhatt, Vince Wu, Saajida Hosein, Tyler Seto, Tenzin Gyaltsen
229 [GO] 2021―Feb―01 The impact of COVID-19 on patients with food protein-induced enterocolitis syndrome (FPIES) and their caregivers. Brit Trogen, Hope Jin, Antonella Cianferoni, Fallon Schultz, Amity Chavez, Anna Nowak-Wegrzyn
230 [GO] 2021―Feb―01 Management of a Immunotherapy Unit During the COVID-19 Outbreak: Building a Resilient Health Care System. Inmaculada Sanchez-Machin, Ruperto Gonzalez Perez, Paloma Poza Guedes, Cristina Alava Cruz, Elena Mederos Luis, Victor Matheu
231 [GO] 2021―Feb―01 COVID-19 pandemia: Atopy and prospective analysis of the clinical evolution of patients infected with the SARS-CoV-2 virus Débora S. Guterres, Ana Carolina Dos Santos, Marina de Almeida Prado Meireles Laubi, Marina Laubi, Roselene Lourenço, Marcus Vinícius, et al. (+5)
232 [GO] 2021―Feb―01 An Institutional Survey of Patient Satisfaction with Telemedicine Services in Pediatric Allergy During the COVID-19 Pandemic Kasey Lanier, Merin Kuruvilla, Jennifer Shih
233 [GO] 2021―Feb―01 Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic Lois Kang, Maya Goldman, Anny Uyehara, Michael Goldman
234 [GO] 2021―Feb―01 Continuing Peanut Oral Immunotherapy via Telemedicine During the COVID-19 Pandemic Anna Schoonover, Anny Uyehara, Michael Goldman
235 [GO] 2021―Feb―01 Assessment of Anxiety, Depression and Resilience in Food-Allergic Adolescents and Primary Caregivers During the COVID-19 Pandemic Ashton Rogers, Emily Seminara, Caitlan Murphy, Diana Munoz-Mendoza, Amika Sood, Ellen Manegold, et al. (+3)
236 [GO] 2021―Feb―01 Utilizing the ASTHMAXcel PRO Mobile Platform to Conduct a Virtual Cohort Study During the COVID-19 Pandemic Emine Cosar, Savneet Kaur, Anjani Singh, Obumneme Njeze, Brian Hsia, Sunit Jariwala
237 [GO] 2021―Feb―01 Remote Data Collection Through the ASTHMAXcel Mobile Application, and Lessons Learned During the COVID-19 Pandemic Brian Hsia, Anjani Singh, Obumneme Njeze, Emine Cosar, Savneet Kaur, Sunit Jariwala
238 [GO] 2021―Feb―01 Changes in food spending among food allergic families following the COVID-19 pandemic Michael Golding, Catherine Lemoine-Courcelles, Elissa Abrams, Moshe Ben-Shoshan, Edmond Chan, Derek Chu, et al. (+5)
239 [GO] 2021―Feb―01 Increased adherence to controller medication maintained during the COVID-19 pandemic Benjamin Theye, Leanne Kaye, Jared Nagano, Rahul Gondalia, Meredith Barrett, David Stempel
240 [GO] 2021―Feb―01 Allergy & Immunology Involvement on Multidisciplinary Treatment Team During COVID-19 Pandemic Veronica Azmy, Kelsey Kaman, Christina Price
241 [GO] 2021―Feb―01 COVID-19 Pandemic and Telehealth: allergy patient perspectives in an urban, academic medical center Darshil Patel, Andrea Pappalardo, Vanessa Harmon, Mary Pasquinelli, Julia Trosman, Christine Weldon, Sharmilee Nyenhuis
242 [GO] 2021―Feb―01 Patient's perceived quality and satisfaction of Teleconsultation Services in an Allergy Department during COVID-19 pandemic era Aida Bermejo-Becerro, Filip Skrabski, Esperanza Pérez-Pallisé, Sandra Rodríguez-Hermida, José Manuel Zubeldia, Alberto Alvarez-Perea
243 [GO] 2021―Feb―01 Implications of the COVID-19 Pandemic on Asthma Control and Socioeconomic Factors in Inner-City Cohort: A Rapid Online Cross-Sectional Survey Thanaporn Ratchataswan, Christina Yee, Caroline Mortelliti, Amparito Cunningham, Lisa Bartnikas, Wanda Phipatanakul
244 [GO] 2021―Feb―01 Consequences of the COVID-19 pandemic on grocery shopping habits of food allergic families Michael Golding, Cathérine Lemoine-Courcelles, Elissa Abrams, Moshe Ben-Shoshan, Philippe Begin, Edmond Chan, et al. (+6)
245 [GO] 2021―Feb―01 Understanding the impact of the COVID-19 pandemic on physical and mental health Shu Cao, Hena Din, Christopher Warren, Jessica Fitzpatrick, Tina Hernandez-Boussard, Manisha Desai, et al. (+2)
246 [GO] 2021―Feb―01 Impact of the COVID-19 pandemic on physical and mental health among individuals with primary immunodeficiency: results of a nationwide survey Deepti Deshpande, Christopher Scalchunes, Jordan Orange, Joshua Milner
247 [GO] 2021―Feb―01 Immunodeficiency during COVID-19 pandemic: analysis of a 243 patients' cohort followed at a Brazilian tertiary hospital Laís Cunha, Priscila Franco, Bruna Gehlen, Mariana Fernandes, Alex Prado, Grazielly Pereira, et al. (+6)
248 [GO] 2021―Feb―01 Asthma care during the COVID-19 pandemic: Differences in attitudes and expectations between physicians and patients Nonie Arora, Desmond Lowe, Nadeen Sarsour, Hannah Jaffee, Sanaz Eftekhari, Laurie Carpenter, et al. (+2)
249 [GO] 2021―Feb―01 Characterization of T cell, B cell and Natural Killer Cell Subsets in COVID-19 Patients Alena Rynda, Andrei Hancharou, Natalia Antonevich, Oxana Timohina, Yana Minich, Alena Halavach, et al. (+4)
250 [GO] 2021―Feb―01 SARS-CoV-2 entry factors are expressed in nasal, ocular, and oral tissues: implications for COVID-19 prophylaxes/therapeutics Ivan Lee, Tsuguhisa Nakayama, Sizun Jiang, Yury Goltsev, Christian Schürch, Bokai Zhu, et al. (+7)
251 [GO] 2021―Feb―01 Risk Factors Associated With COVID-19 Related Anosmia And Ageusia Esha Sehanobish, Mali Barbi, Valerie Fong, Meryl Kravitz, Cynthia Matsumura, Denise Tejera, et al. (+14)
252 [GO] 2021―Feb―01 Going Beyond Virus Biology: COVID-19's Impact on the Mental Health of Pediatric Populations in an Allergy Community Jason Ohayon, Tenzin Gyaltsen, Tyler Seto, Vaidehi Bhatt, Wardha. Wardha, Ijaz Ogeer, et al. (+2)
253 [GO] 2021―Feb―01 COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain. Alicia Domínguez Estirado, Gabriela Zambrano Ibarra, Filip Skrabski, Francisco Javier De Castro Martínez, Julia De Pedro, Maria Pilar Sanz Sanz, et al. (+2)
254 [GO] 2021―Feb―01 COVID-19 severity in asthma patients: A multi-center matched cohort study Lacey Robinson, Liqin Wang, Xiaoquing Fu, Zachary Wallace, Aidan Long, Yuqing Zhang, et al. (+2)
255 [GO] 2021―Feb―01 COVID-19 Severity in Hospitalized Pediatric Patients with Atopic Disease Dylan Timberlake, Rebecca Scherzer, Benjamin Prince, Mitchell Grayson
256 [GO] 2021―Feb―01 Recent Mumps-Measles-Rubella Vaccination Probably Reduces COVID-19 Severity: A Proposed Strategy For Close-Contacts Of Patients Desiree Larenas - Linnemann, Fernanda Rodríguez Monroy
257 [GO] 2021―Feb―01 Intensive Infection Control at a Canadian Tertiary Allergy and Clinical Immunology Clinic during COVID-19 to Provide Crucial Services Jodi Valois, Hoang Pham, Derek Lanoue, Tim Olynych, William Yang
258 [GO] 2021―Feb―01 SARS-CoV-2 full length spike protein for COVID-19 vaccine development and diagnostic testing Crystal Richardson, Mayuresh Abhyankar, Jillian Bracaglia, Sayeh Agah, Zachary Schuhmacher, Bryan Smith, et al. (+4)
259 [GO] 2021―Feb―01 A COVID-19 vaccine success? patients perception of Covid vaccination program Wardha. Wardha, Vaidehi Bhatt, Tyler Seto, Vince Wu
260 [GO] 2021―Feb―01 COVID-19-Associated Hospitalization and Outcomes in Patients with Asthma: A Systematic Review and Meta-analysis Andrea Sitek, Justine Ade, Mitchell M. Pitlick, Sergio Chiarella, Rohit Divekar, Vivek Iyer, et al. (+2)
261 [GO] 2021―Feb―01 Implementation of Virtual Training Visits During the Coronavirus Pandemic: a Nursing Perspective Linda Trotto, Christopher Vanname, Timothy Kingas
262 [GO] 2021―Feb―01 Does Point-Of-Care SARS-CoV-2 Antibody Testing Have Similar Sensitivity and Specificity To High Complexity Serology? Kelly O'Shea, Charles Schuler, Jesse Chen, Carmen Gherasim, Donald Giacherio, James Baldwin, James Baker
263 [GO] 2021―Feb―01 An effective approach for recombinant production of select SARS-CoV-2 proteins in Escherichia coli Sayeh Agah, Catherine Thorpe, Martin Chapman, Sabina Wuenschmann
264 [GO] 2021―Feb―01 Quantitative Measurement of IgG to SARS-CoV-2 Proteins Using the Phadia ImmunoCAP 250 Behnam Keshavarz, Joseph Wiencek, Lindsay Bazydlo, Matthew Straesser, Lisa Workman, Thomas Platts-Mills, Jeffrey Wilson
265 [GO] 2021―Feb―01 Cellular and humoral immunity in patients infected with the SARS-CoV-2 virus at general hospital Valéria Brandão, Thaís T. Saito, Débora S. Guterres, Grasiele Lima, Sara Tencarte, Ana Carolina Dos Santos, et al. (+7)
266 [GO] 2021―Feb―01 Clinical Characteristics of SARS-CoV2 Infected and Exposed Patients at a Tertiary Care Allergy/Immunology Program in Florida Mary Ann Miranda, Joseph Dasso, Maryssa Ellison, Jessica Trotter, Priyanka Timothy, Maria Chitty-Lopez, et al. (+9)
267 [GO] 2021―Feb―01 Outcomes of SARS-CoV2 infection in STAT3 and PGM3 Deficiency Muhammad Khalid, Amanda Urban, Dirk Darnell, Alexandra Freeman
268 [GO] 2021―Feb―01 Prolonged Maintenance Interval Of Allergen Subcutaneous Immunotherapy during COVID19 pandemic Jaspreet Dhami, Vivian Wang, Mohamed Eloustaz, Joseph Yusin
269 [GO] 2021―Feb―01 How To Care For Errors of Innate Immunity (EII) Patients During The Pandemic In a Developing Country Without Telemedicine? Raissa Roque, Fernanda Vaz, Rafael Saldanha, Caroline Ferreira, Nathalia Vital, Pedro Bubach, et al. (+6)
270 [GO] 2021―Jan―22 Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies Matthew T. Patrick, Haihan Zhang, Rachael Wasikowski, Errol P. Prens, Stephan Weidinger, Johann E. Gudjonsson, et al. (+3)
271 [GO] 2021―Jan―19 mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis Tiago Azenha Rama, André Moreira, Mariana Castells
272 [GO] 2020―Dez―17 Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2 Terrie S. Ahn, Brandon Han, Paul Krogstad, Chantana Bun, Lisa A. Kohn, Maria I. Garcia-Lloret, et al. (+2)
273 [GO] 2020―Dez―16 COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. Adrian M. Shields, Siobhan O. Burns, Sinisa Savic, Alex G. Richter
274 [GO] 2020―Dez―03 Marked changes in innate immunity associated with a mild course of COVID-19 in identical twins with athymia and absent circulating T cells Argentina Colmenero Velázquez, Gloria Esteso, Teresa del Rosal, Ane Calvo Apalategui, Hugh Reyburn, Eduardo López-Granados
275 [GO] 2020―Nov―20 Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19 Carlo Cervia, Jakob Nilsson, Yves Zurbuchen, Alan Valaperti, Jens Schreiner, Aline Wolfensberger, et al. (+19)
276 [GO] 2020―Nov―19 Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study Giorgio Bozzi, Davide Mangioni, Francesca Minoia, Stefano Aliberti, Giacomo Grasselli, Laura Barbetta, et al. (+20)
277 [GO] 2020―Nov―05 Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: a Northern Italy experience Gisondi Paolo, Piaserico Stefano, Naldi Luigi, Dapavo Paolo, Conti Andrea, Malagoli Piergiorgio, et al. (+17)
278 [GO] 2020―Nov―05 The United States’ Reckoning with Racism during the COVID-19 pandemic: What can we learn and do as Allergist-Immunologists? Lakiea S. Wright, Margee Louisias, Wanda Phipatanakul
279 [GO] 2020―Okt―28 Pathways for Bradykinin Formation and Interrelationship with Complement as a Cause of Edematous Lung in COVID-19 Patients Allen P. Kaplan, Berhane Ghebrehiwet
280 [GO] 2020―Okt―26 Eosinophilic pulmonary vasculitis as a manifestation of the hyperinflammatory phase of COVID-19 Eva Luecke, Andreas Jeron, Andrea Kroeger, Dunja Bruder, Sabine Stegemann-Koniszewski, Doerthe Jechorek, et al. (+7)
281 [GO] 2020―Okt―23 Compartmental immunophenotyping in COVID-19 ARDS: A case series Andreas Ronit, Ronan M.G. Berg, Jakob T. Bay, Anna K. Haugaard, Magnus G. Ahlström, Kristoffer S. Burgdorf, et al. (+7)
282 [GO] 2020―Okt―16 COVID-19 Associated Multisystem Inflammatory Syndrome in Children (MIS-C): a novel disease that mimics Toxic Shock Syndrome. The superantigen hypothesis Magali Noval Rivas, Rebecca A. Porritt, Mary Hongying Cheng, Ivet Bahar, Moshe Arditi
283 [GO] 2020―Okt―16 Factors associated with adverse COVID-19 outcomes in patients with psoriasis - insights from a global registry-based study Satveer K. Mahil, Nick Dand, Kayleigh J. Mason, Zenas ZN. Yiu, Teresa Tsakok, Freya Meynell, et al. (+30)
284 [GO] 2020―Okt―15 Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon Lydia J. Finney, Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V. Kemp, et al. (+8)
285 [GO] 2020―Okt―09 COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department Mathias Van Singer, Thomas Brahier, Michelle Ngai, Julie Wright, Andrea M. Weckman, Clara Erice, et al. (+4)
286 [GO] 2020―Sep―30 IL-6 serum levels predict severity and response to Tocilizumab in COVID-19: an observational study José María Galván-Román, Sebastián C. Rodríguez-García, Emilia Roy-Vallejo, Ana Marcos-Jiménez, Santiago Sánchez-Alonso, Carlos Fernández-Díaz, et al. (+33)
287 [GO] 2020―Sep―30 Severe SARS-CoV-2 Disease In The Context Of A NFκB2 Loss-Of-Function Pathogenic Variant Roshini S. Abraham, Joanna M. Marshall, Hye Sun Kuehn, Cesar M. Rueda, Amber Gibbs, Will Guider, et al. (+13)
288 [GO] 2020―Sep―29 COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids Eftychios Siniorakis, Spyridon Arvanitakis, Titika Sfakianaki, Antonios Katsianis, Athanasios Sinaniotis, Veneta Papagiannopoulou
289 [GO] 2020―Sep―29 Asthma-associated risk for COVID-19 development Chrysanthi Skevaki, Antonina Karsonova, Alexander Karaulov, Min Xie, Harald Renz
290 [GO] 2020―Sep―29 Pulmonary edema in COVID-19: Explained by bradykinin? Suzanne Zwaveling, Roy Gerth van Wijk, Faiz Karim
291 [GO] 2020―Sep―24 Coronavirus Disease 2019 in patients with inborn errors of immunity: an international study Isabelle Meyts, Giorgia Bucciol, Isabella Quinti, Bénédicte Neven, Alain Fischer, Elena Seoane, et al. (+49)
292 [GO] 2020―Sep―21 Elevated plasma sTIM-3 levels in severe Covid-19 patients Thor Ueland, Lars Heggelund, Andreas Lind, Aleksander R. Holten, Kristian Tonby, Annika E. Michelsen, et al. (+20)
293 [GO] 2020―Sep―17 Whether the timing of patient randomization interferes with the assessment of the efficacy of ruxolitinib for severe COVID-19 Hailan Li, Huaping Liu
294 [GO] 2020―Sep―10 Characterization of the Cytokine Storm Reflects Hyperinflammatory Endothelial Dysfunction in COVID-19 Jonathan T. Sims, Venkatesh Krishnan, Ching-Yun Chang, Sarah M. Engle, Giacomo Casalini, George H. Rodgers, et al. (+11)
295 [GO] 2020―Sep―04 The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection Ana Copaescu, Olivia Smibert, Andrew Gibson, Elizabeth J. Phillips, Jason A. Trubiano
296 [GO] 2020―Sep―04 The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
297 [GO] 2020―Aug―15 Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study Jee Myung Yang, Hyun Yong Koh, Sung Yong Moon, In Kyung Yoo, Eun Kyo Ha, Seulgi You, et al. (+3)
298 [GO] 2020―Aug―14 COVID-19: Start with the nose Brian Lipworth, Rory Chan, Chris RuiWen Kuo
299 [GO] 2020―Aug―06 Asthma Among Hospitalized Patients with COVID-19 and Related Outcomes Stephanie Lovinsky-Desir, Deepti R. Deshpande, Aliva De, Laurie Murray, Jeanette A. Stingone, Angela Chan, et al. (+5)
300 [GO] 2020―Jul―29 Risk factors for hospitalization, intensive care and mortality among patients with asthma and COVID-19 Liqin Wang, Dinah Foer, David W. Bates, Joshua A. Boyce, Li Zhou
301 [GO] 2020―Jul―23 Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities Zita-Rose Manjaly Thomas, Anne Leuppi-Taegtmeyer, Dagmar Jamiolkowski, Esther Steveling-Klein, Felicitas Bellutti-Enders, Kathrin Scherer Hofmeier, Karin Hartmann
302 [GO] 2020―Jul―22 Interleukin-6-based mortality risk model for hospitalised COVID-19 patients Laguna-Goya Rocio, Utrero-Rico Alberto, Talayero Paloma, Lasa-Lazaro Maria, Ramirez-Fernandez Angel, Naranjo Laura, et al. (+11)
303 [GO] 2020―Jul―03 Nucleic Acid Approaches to Antibody-based Therapeutics for COVID-19: A Perspective Elizabeth Parzych, David B. Weiner
304 [GO] 2020―Jul―02 Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective Koa Hosoki, Abhijit Chakraborty, Sanjiv Sur
305 [GO] 2020―Jun―22 Asthmatic patients in COVID-19 outbreak: Few cases despite many cases Marco Caminati, Carlo Lombardi, Claudio Micheletto, Elena Roca, Barbara Bigni, Fabiana Furci, et al. (+3)
306 [GO] 2020―Jun―17 Risk and Management of Patients with Mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) Pandemic: Expert Opinions * Peter Valent, Cem Akin, Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, Boguslaw Nedoszytko, et al. (+20)
307 [GO] 2020―Jun―15 Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19 Krishan D. Chhiba, Gayatri B. Patel, Thanh Huyen T. Vu, Michael M. Chen, Amina Guo, Elizabeth Kudlaty, et al. (+13)
308 [GO] 2020―Jun―13 Molecular pharmacology of ciclesonide against SARS-CoV-2 Hirokazu Kimura, Hiromu Kurusu, Mitsuru Sada, Daisuke Kurai, Koichi Murakami, Wataru Kamitani, et al. (+3)
309 [GO] 2020―Jun―10 Prevalence of comorbid asthma in COVID-19 patients Marcus W. Butler, Aoife O’Reilly, Eleanor M. Dunican, Patrick Mallon, Eoin R. Feeney, Michael P. Keane, Cormac McCarthy
310 [GO] 2020―Jun―10 Expression of SARS-CoV-2 Receptor ACE2 and Coincident Host Response Signature Varies by Asthma Inflammatory Phenotype Matthew J. Camiolo, Marc Gauthier, Naftali Kaminski, Anuradha Ray, Sally E. Wenzel
311 [GO] 2020―Jun―06 Association of asthma and its genetic predisposition with the risk of severe COVID-19 Zhaozhong Zhu, Kohei Hasegawa, Baoshan Ma, Michimasa Fujiogi, Carlos A. Camargo, Liming Liang
312 [GO] 2020―Mai―29 Successful use of methylprednisolone for treating severe COVID-19 Jing Liu, Xiaobin Zheng, Yiying Huang, Hong Shan, Jin Huang
313 [GO] 2020―Mai―29 SARS-CoV-2 Antibody Testing - Questions to be asked Mustafa K. Özçürümez, Andreas Ambrosch, Oliver Frey, Verena Haselmann, Stefan Holdenrieder, Michael Kiehntopf, et al. (+5)
314 [GO] 2020―Mai―28 The bimodal SARS-CoV-2 outbreak in Italy as an effect of environmental and allergic causes Salvatore Chirumbolo, Geir Bjørklund
315 [GO] 2020―Mai―26 Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial Yang Cao, Jia Wei, Liang Zou, Tiebin Jiang, Gaoxiang Wang, Liting Chen, et al. (+15)
316 [GO] 2020―Mai―26 Does asthma affect morbidity or severity of Covid-19? Kenji Matsumoto, Hirohisa Saito
317 [GO] 2020―Mai―22 ACE2, TMPRSS2 AND FURIN GENE EXPRESSION IN THE AIRWAYS OF PEOPLE WITH ASTHMA - IMPLICATIONS FOR COVID-19 Peter Bradding, Matthew Richardson, Timothy S.C. Hinks, Peter H. Howarth, David F. Choy, Joseph R. Arron, et al. (+2)
318 [GO] 2020―Mai―20 Clinical Testing For Covid-19 Stephanie Ward, Andrew Lindsley, Josh Courter, Amal Assa’ad
319 [GO] 2020―Mai―18 Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19 Tobias Herold, Vindi Jurinovic, Chiara Arnreich, Brian J. Lipworth, Johannes C. Hellmuth, Michael von Bergwelt-Baildon, et al. (+2)
320 [GO] 2020―Mai―16 Perforin and resistance to SARS coronavirus 2 Louise Cunningham, Peter Simmonds, Ian Kimber, David Arthur Basketter, John Paul McFadden
321 [GO] 2020―Mai―15 COVID-19 infection in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab Ulrike Förster-Ruhrmann, Agnieszka J. Szczepek, habil Claus Bachert, habil Heidi Olze
322 [GO] 2020―Mai―14 COMPLEMENT ACTIVATION IN PATIENTS WITH COVID-19: A NOVEL THERAPEUTIC TARGET Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, Samantha Griffini, Elena Grovetti, Adriana Torri, et al. (+5)
323 [GO] 2020―Mai―12 Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients - a perspective Lennart Hammarström, Hassan Abolhassani, Fausto Baldanti, Harold Marcotte, Qiang Pan-Hammarström
324 [GO] 2020―Mai―11 Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease Emanuele Pontali, Stefano Volpi, Giancarlo Antonucci, Marco Castellaneta, Davide Buzzi, Francesca Tricerri, et al. (+9)
325 [GO] 2020―Mai―11 Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China Ruchong Chen, Ling Sang, Mei Jiang, Zhaowei Yang, Nan Jia, Wanyi Fu, et al. (+29)
326 [GO] 2020―Mai―11 The immunologic status of newborns born to SARS-CoV2-infected mothers in Wuhan, China Pin Liu, Junwen Zheng, Pu Yang, Xia Wang, Cong Wei, Shiyu Zhang, et al. (+6)
327 [GO] 2020―Mai―08 COVID-19: unanswered questions on immune response and pathogenesis Enrico Maggi, Giorgio Walter Canonica, Lorenzo Moretta
328 [GO] 2020―Mai―07 Air pollution, racial disparities and COVID-19 mortality Eric B. Brandt, Andrew F. Beck, Tesfaye B. Mersha
329 [GO] 2020―Mai―01 Perspective: COVID-19, Implications of nasal diseases and consequences for their management Li Jian, Wei Yi, Nan Zhang, Wen Weiping, Olga Krysko, Woo-Jung Song, Claus Bachert
330 [GO] 2020―Apr―29 Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 Yang Yang, Chenguang Shen, Jinxiu Li, Jing Yuan, Jinli Wei, Fengmin Huang, et al. (+19)
331 [GO] 2020―Apr―29 Type I IFN immunoprofiling in COVID-19 patients Sophie Trouillet-Assant, Sebastien Viel, Alexandre Gaymard, Sylvie Pons, Jean-Christophe Richard, Magali Perret, et al. (+6)
332 [GO] 2020―Apr―27 COVID-19 diagnostic process in mainland China: the math beyond pneumonia Feng Wu, Weishan Huang
333 [GO] 2020―Apr―27 Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination Andrew W. Lindsley, Justin T. Schwartz, Marc E. Rothenberg
334 [GO] 2020―Apr―27 Will environmental impacts of social distancing due to the SARS-CoV-2 pandemic decrease allergic disease? Valentin Navel, Frédéric Chiambaretta, Frédéric Dutheil
335 [GO] 2020―Apr―22 A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia Isabella Quinti, Vassilios Lougaris, Cinzia Milito, Francesco Cinetto, Antonio Pecoraro, Ivano Mezzaroma, et al. (+9)
336 [GO] 2020―Apr―22 Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2 Daniel J. Jackson, William W. Busse, Leonard B. Bacharier, Meyer Kattan, George T. O’Connor, Robert A. Wood, et al. (+10)
337 [GO] 2020―Apr―16 An academic allergy unit during COVID-19 pandemic in Italy Giacomo Malipiero, Giovanni Paoletti, Francesca Puggioni, Francesca Racca, Sebastian Ferri, Antonino Marsala, et al. (+5)
338 [GO] 2020―Apr―12 Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Xiaochen Li, Shuyun Xu, Muqing Yu, Ke Wang, Yu Tao, Ying Zhou, et al. (+12)
339 [GO] 2020―Mrz―31 Running a virtual allergy division and training program in the time of COVID-19 pandemic Christopher D. Codispoti, Sindhura Bandi, James Moy, Mahboobeh Mahdavinia
340 [GO] 2019―Dez―04 The role of the changing human microbiome in the asthma pandemic Timothy C. Borbet, Xiaozhou Zhang, Anne Müller, Martin J. Blaser
341 [GO] 2019―Dez―04 The role of the changing human microbiome in the asthma pandemic
 [1] 

341 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.009 sec